BURROWS SCOTT L (Chief Financial Officer) sold 7.1% of their position (7.50K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $370.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/3/2026ACC: 0001853327-26-000003
Officer· Chief Financial Officer
Since Mar 2026
-7.50K
Net shares
Net seller
$370.1K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
7.50K acquired · 15K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+7.50K
Price / share
$14.50
Trade value
$108.75K
% of position
7.7%
4/1/2026
97.99K→105.49K
Common Stock
Direct
Shares
−6.20K
Price / share
$49.21
Trade value
$305.10K
% of position
5.9%
4/1/2026
105.49K→99.29K
Common Stock
Direct
Shares
−1.30K
Price / share
$49.98
Trade value
$64.97K
% of position
1.3%
4/1/2026
99.29K→97.99K
Total
Net shares
+0.00
Net value
-$261.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | M · Option Exercise | +7.50K | $14.50 | $108.75K | 7.7% | 97.99K | 105.49K |
| Common Stock Direct | 4/1/2026 | S · Sale | −6.20K | $49.21 | $305.10K | 5.9% | 105.49K | 99.29K |
| Common Stock Direct | 4/1/2026 | S · Sale | −1.30K | $49.98 | $64.97K | 1.3% | 99.29K | 97.99K |
| Total | +0.00 | -$261.33K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.50K shares
Shares
−7.50K
Strike price
14.50
Held after
394.86K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock7.50K shares | 4/1/2026 | M · Option Exercise | −7.50K | 14.50 | — | 394.86K |